Beyond Final Testing: Building Quality Through in-Process Quality Control In Pharmaceutical Manufacturing

Abstract

The pharmaceutical industry is responsible for ensuring that medicinal products are consistently manufactured to meet the highest standards of quality, safety, and efficacy. In-Process Quality Control (IPQC) is an integral part of pharmaceutical quality assurance that involves continuous monitoring and testing of materials, manufacturing processes, and finished dosage forms throughout production. The primary objective of IPQC is to detect process variations at an early stage, implement timely corrective actions, and maintain batch-to-batch consistency while ensuring compliance with regulatory requirements and Good Manufacturing Practices (GMP). This review provides a comprehensive overview of the principles, objectives, and major stages of IPQC, including in-process checks, manufacturing operations, sampling, in-process testing, and packaging controls. It also summarizes the critical in-process quality control tests performed for solid, semisolid, liquid, and sterile dosage forms, such as hardness, friability, weight variation, content uniformity, disintegration, pH, viscosity, sterility, particulate matter, and leakage tests. Furthermore, the review discusses the importance of pharmaceutical documentation, including Standard Operating Procedures (SOPs), Batch Manufacturing Records (BMRs), Master Formula Records (MFRs), Drug Master Files (DMFs), Common Technical Documents (CTDs), and audit trails, in maintaining data integrity, traceability, and regulatory compliance. The effective implementation of IPQC enhances manufacturing efficiency, minimizes product rejection, reduces process deviations, and ensures the consistent production of safe, effective, and high-quality pharmaceutical products that comply with pharmacopeial standards and global regulatory expectations.